Revista de medicina de la Universidad de Navarra
View on PubMed
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Slides referencing similar topics
Cox-2 Inhibitors: Where Are We ? Overview of Celecoxib Clinical Trials Phase Iii Pivotal Oa Trials : Study Design
Paul M. Tulkens • Mar 19, 2015
Celecoxib 8th in terms of prescription volume for selected products in pediatric patients Trends in prescription volume (pediatric)2
Hari Cheryl Sachs • Oct 15, 2017
Purpose: Comparison of the chronic (used NSAIDs 6 months or more for pain relief) use of celecoxib (cox- 2 inhibitor) to naproxen and ibuprofen (non-selective NSAIDs) in arthritis patients at risk for or with coronary artery disease (CAD) for blood pressure effects. Trial Design: Sub-study of the PRECISION trial. Double-blinded, randomized 1:1:1, non-inferiority, safety
Oct 10, 2017